Neuroendocrine cancers (NC) are England’s tenth most prevalent cancer. Yet awareness of these cancers is very low, even among healthcare professionals (HCPs). People living with NC experience inequities in diagnosis, disease management and care due to a lack of...
Understanding Neuroendocrine Cancer. Spotlight on Pancreatic Neuroendocrine Cancer, presented by Mike Tadman, Senior Clinical Nurse Specialist in Neuroendocrine Tumours at Churchill Hospital, Oxford. Recorded at the NCUK’s Virtual Summit 2020....
RESEARCH SPOTLIGHT MARCH 2021 – CLINICAL TRIALS IN NEUROENDOCRINE CANCER. Patient and public involvement (PPI) in research is a very welcome and increasingly frequent requirement due to the potential benefits in the design of participant and researcher relevant,...
